Glucose-dependent insulinotropic polypeptide stimulates the proliferation of colorectal cancer cells

Regulatory Peptides

Volumn 163, Issue 1-3, 2010, Pages 74-80

  Prabakaran, Daniel ^a   Wang, Baogui ^a   Feuerstein, Joseph D ^a   Sinclair, Jennifer A ^a   Bijpuria, Priti ^a   Jepeal, Lisa I ^a   Wolfe, M Michael ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Akt; Colorectal cancer; GIP; Glucose dependent insulinotropic polypeptide; MTOR; Obesity

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GASTRIC INHIBITORY POLYPEPTIDE RECEPTOR; HORMONE RECEPTOR; INSULIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; COLORECTAL CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INSULIN RELEASE; LIGAND BINDING; MOLECULAR EVOLUTION; MOUSE; NONHUMAN; NUTRIENT; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; BINDING SITES; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; GASTRIC INHIBITORY POLYPEPTIDE; HUMANS; LIGANDS; MICE; OBESITY; RECEPTORS, GASTROINTESTINAL HORMONE; SWINE;

EID: 77953914572     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2010.04.005     Document Type: Article

References (38)

1. Chang A.J., Song D.H., Wolfe M.M. Gastrin stimulation of colorectal cancer cell proliferation is mediated in part by attenuation of peroxisome proliferator activated receptor gamma (PPAR) activity and proteasomal degradation of PPARγ protein. J Biol Chem 2006, 281:14700-14710.
2. Nakata H., Wang S.-L., Chung D.C., Westwick J.K., Tillotson L.G. Oncogenic Ras induces gastrin gene expression in colon cancer. Gastroenterology 1998, 115:1144-1153.
3. Fearnon R.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767.
4. Cummings D.E., Weigle D.S., Frayo S., Breen P.A., Ma M.K., Dellinger E.P., Purnell J.Q. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002, 346:1623-1630.
5. Ogden C.L., Carroll M.D., Curtin L.R., McDowell M.A., Tabak C.J., Flegal K.M. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006, 295:1549-1555.
6. Calle E.E., Rodriguez C., Walker-Thurmond K., Thun M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003, 348:1625-1638.
7. Song D.H., Getty-Kaushik L., Tseng E., Simon J., Corkey B.E., Wolfe M.M. Glucose-dependent insulinotropic polypeptide enhances adipocyte development and glucose uptake in part through Akt activation. Gastroenterology 2007, 123:1796-1805.
8. Service F.J., Rizza R.A., Westland R.E., Hall L.D., Gerich J.E., Go V.L. Gastric inhibitory polypeptide in obesity and diabetes mellitus. J Clin Endocrinol Metab 1984, 58:1133-1140.
9. Ebert R., Frerichs H., Creutzfeldt W. Impaired feedback control of fat induced gastric inhibitory polypeptide (GIP) secretion by insulin in obesity and glucose intolerance. Eur J Clin Invest 1979, 9:129-135.
10. Groop P.H. The influence of body weight, age and glucose tolerance on the relationship between GIP secretion and beta-cell function in man. Scand J Clin Lab Invest 1989, 49:367-379.
11. Pederson R.A., Kieffer T.J., Pauly R., Kofod H., Kwong J., McIntosh C.H. The enteroinsular axis in dipeptidyl peptidase IV-negative rats. Metabolism: Clin Exp 1996, 45:1335-1341.
12. Miyawaki K., Yamada Y., Ban N., Ihara Y., Tsukiyama K., Zhou H., Fujimoto S., Oku A., Tsuda K., Toyokuni S., Hiai H., Mizunoya W., Fushiki T., Holst J.J., Makino M., Tashita A., Kobara Y., Tsubamoto Y., Jinnouchi T., Jomori T., Seino Y. Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med 2002, 8:738-742.
13. Kim S.-J., Nian C., Widenmaier S., McIntosh C.H.S. Glucose-dependent insulinotropic polypeptide-mediated up-regulation of ∃-cell antiapoptotic Bcl-2 gene expression is coordinated by cyclic AMP (cAMP) response element binding protein (CREB) and cAMP-responsive CREB coactivator 2. Mol Cell Biol 2008, 28:1644-1656.
14. Kodach L.L., Bos C.L., Durán N., Peppelenbosch M.P., Ferreira C.V., Hardwick J.C.H. Violacein synergistically increases 5-fluorouracil cytotoxicity, induces apoptosis and inhibits Akt-mediated signal transduction in human colorectal cancer cells. Carcinogenesis 2006, 27:508-516.
15. Sabatini D.M. mTOR and cancer: insights into a complex relationship. Nat Rev 2006, 6:729-734.
16. Sarbassov D.D., Ali S.M., Sabatini D.M. Growing roles for the mTOR pathway. Curr Opin Cell Biol 2005, 17:596-603.
17. Kubota A., Yamada Y., Yasuda K., Someya Y., Ihara Y., Kagimoto S., Watanabe R., Kuroe A., Ishida H., Seino Y. Gastric inhibitory polypeptide activates MAP kinase through the wortmannin-sensitive and -insensitive pathways. Biochem Biophys Res Commun 1997, 235:171-175.
18. Wolfe M.M., Hocking M.P., Maico D.G., McGuigan J.E. Effects of antibodies to gastric inhibitory peptide on gastric acid secretion and gastrin release in the dog. Gastroenterology 1983, 84:941-948.
19. Moore B., Edie E.S., Abram J.H. On the treatment of diabetes mellitus by acid extract of duodenal mucous membrane. Biochem J 1906, 1:26-38.
20. Wang Z., Wang R.M., Owji A.A., Smith D.M., Ghatei M.A., Bloom S.R. Glucagon-like peptide-1 is a physiological incretin in rat. J Clin Invest 1995, 95:417-421.
21. Tseng C.C., Kieffer T.J., Jarboe L.A., Usdin T.B., Wolfe M.M. Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat. J Clin Invest 1996, 98:2440-2445.
22. Eckel R.H., Fujimoto W.Y., Brunzell J.D. Gastric inhibitory polypeptide enhanced lipoprotein lipase activity in cultured preadipocytes. Diabetes 1979, 28:1141-1142.
23. Knapper J.M., Puddicombe S.M., Morgan L.M., Fletcher J.M. Investigations into the actions of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (7-36) amide on lipoprotein lipase activity in explants of rat adipose tissue. J Nutrition 1995, 125:183-188.
24. Althage M.C., Ford E.L., Wang S., Tso P., Polonsky K.S., Wice B.M. Targeted ablation of GIP-producing cells in transgenic mice reduces obesity and insulin resistance induced by high fat diet. J Biol Chem 2008, 283:18365-18376.
25. Lew E.A., Garfinkel L. Variations in mortality by weight among 750,000 men and women. J Chronic Dis 1979, 32:563-576.
26. Frezza E.E., Wachtel M.S., Chiriva-Internati M. Influence of obesity on the risk of developing colon cancer. Gut 2006, 55:285-291.
27. Kaaks R., Toniola P., Akhmedkhanov A., Lukanova A., Biessy C., Dechaud H., Rinaldi S., Zeleniuch-Jacquotte A., Shore R.E., Riboli E. Serum c-peptide, insulin-like growth factor (IGF)-1, IGF binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 2000, 92:1592-1600.
28. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 2001, 131:3109S-3120S.
29. Higginbotham S., Zhang Z.F., Lee I.M., Cook N.R., Giovannucci E., Buring J.E., Liu S. Dietary glycemic load and risk of colorectal cancer in the Women's Health Study. J Natl Cancer Inst 2004, 96:229-233.
30. Sridhar S.S., Goodwin P.J. Insulin-insulin-like growth factor axis and colon cancer. J Clin Oncol 2009, 27:165-167.
31. Zhao L. Class I PI3K in oncogenic cellular transformation. Oncogene 2008, 27:5486-5496.
32. Huang X-F, Chen J-Z Obesity, the PI3/Akt signal pathway and colon cancer. Obes. Rev. 2009, 10:610-616.
33. Fearnon R.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767.
34. Hursting S.D., Nunez N.P., Varticovski L., Vinson C. The obesity-cancer link: lessons learned from a fatless mouse. Cancer Res 2007, 67:2391-2393.
35. Wullschleger S., Loewith R., Hall M.N. TOR signaling in growth and metabolism. Cell 2006, 124:471-484.
36. Widenmaier S.B., Sampaio A.V., Underhill T.M., McIntosh C.H.S. Noncanonical activation of Akt/protein kinase B in ∃cells by the incretin hormone glucose-dependent insulinotropic polypeptide. J Biol Chem 2009, 284:10764-10773.
37. Trümper A., Trümper K., Hörsch D. Mechanisms of mitogenic and anti-apoptotic signaling by glucose-dependent insulinotropic polypeptide in ((INS-1)-cells. J Endocrinol 2002, 174:233-246.
38. Kim S.-J., Winter K., Nian C., Tsuneoka M., Koda Y., McIntosh C.H.S. Glucose-dependent insulinotropic polypeptide stimulation of pancreatic ∃-cell survival is dependent upon phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) signaling, inactivation of the forkhead transcription factor Foxo1, and down-regulation of bax expression. J Biol Chem 2005, 280:22297-22307.